Law360, New York (August 24, 2012, 12:57 PM ET) -- Life sciences companies breathed a sigh of relief when the U.S. Supreme Court largely upheld the Patient Protection and Affordable Care Act (PPACA). After all, the PPACA will add millions of Americans to the pool of health care consumers.
But the Supreme Court also held that the federally subsidized Medicaid expansion is optional for the states; therefore, as recently confirmed by the U.S. Congressional Budget Office, fewer people will be added to the pool than originally projected.
As a result, drug manufacturers might not receive the...
PPACA: What’s Next For Life Sciences Companies
To view the full article, take a free trial now.
